1. Home
  2. CUE vs IH Comparison

CUE vs IH Comparison

Compare CUE & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$25.60

Market Cap

233.5M

Sector

Health Care

ML Signal

N/A

Logo iHuman Inc.

IH

iHuman Inc.

N/A

Current Price

$1.14

Market Cap

58.8M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CUE
IH
Founded
2014
1996
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
233.5M
58.8M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CUE
IH
Price
$25.60
$1.14
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $88.00
N/A
AVG Volume (30 Days)
★ 353.1K
4.5K
Earning Date
11-11-2026
09-29-2026
Dividend Yield
N/A
★ 8.73%
EPS Growth
★ 61.11
N/A
EPS
N/A
★ N/A
Revenue
★ $27,466,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$7.30
Revenue Growth
★ 195.75
N/A
52 Week Low
$0.17
$1.11
52 Week High
$45.50
$3.09

Technical Indicators

Market Signals
Indicator
CUE
IH
Relative Strength Index (RSI) 42.64 41.04
Support Level $23.51 N/A
Resistance Level $33.11 $1.38
Average True Range (ATR) 4.91 0.04
MACD -0.83 0.00
Stochastic Oscillator 11.41 33.33

Price Performance

Historical Comparison
CUE
IH

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

Share on Social Networks: